JZJian-Yi Zheng

Jian-Yi Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian-Yi Zheng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Ren-Dan Zhang

    Department of Geriatrics, Shenzhen Longhua District Central Hospital, Shenzhen, Guang Dong, P.R. China

    1 shared publication
  • Rong Chen

    Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China

    1 shared publication
  • Tu-Di Li

    Cardiovascular Department of First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China

    1 shared publication
  • Tudi Li

    Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China

    1 shared publication
  • Xing Yu

    Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China

    1 shared publication
  • Yan-Qun Zhao

    Cardiovascular Department of First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Impact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol

    by Yuhong Liu, Zhihuan Zeng, Xing Yu, Tudi Li, Yusi Yao, Rong Chen, Jianyi Zheng

    The purpose of this study is to investigate the effect of lipoprotein(a) level on long-range prognosis after Percutaneous Coronary Intervention (PCI) in patients with low-density lipoprotein cholesterol (LDL-C) goal attainment. In this retrospective study, 350 patients in Coronary artery disease (CAD) with LDL-C less than 1.8 mmol/L were enrolled in the Guangdong Institute of Cardiovascular Diseases from January 2011 to December 2013. Follow-up was 1 year after PCI. According to the median value of the study population based on Lp(a), the patients were assigned to the high-level group and low-level group. The clinical data of the 2 groups were collected. We compared the baseline data between the 2 groups and the incidence rate of major cardiovascular events. After statistical analysis, the gender composition, hypertension, diabetes, and age of the patients between the 2 groups were similar, and the distinction was not significant. There was no significant distinction in cardio-vascular death, ischemic stroke, and recurrent myocardial infarction between the 2 groups, but the incidence of revascularization was higher in the high-level group (P < 0.05). High Lp(a) level predicts an increased incidence of revascularization of patients in CAD with LDL-C less than 1.8 mmol/L after PCI.


  • Open Access

    Left atrial myxoma complicated with multi-system embolization

    by Ren-Dan Zhang, Zhi-Huan Zeng, Jian-Yi Zheng, Tu-Di Li, Yan-Qun Zhao, Yu-Hong Liu, Yu-Si Yao

    Atrial myxoma accounts for approximately 50% of all cardiac tumors. The majority of myxomas are located in the left atrium and present variable clinical manifestation. A young man was transferred to our hospital with sudden onset of resting pain, pallor and numb in right leg. An atrial mobile mass was detected by transthoracic echocardiography. Anticoagulant and antithrombotic therapy were administered, a timely surgery was performed and the mass was confirmed as a myxoma. The patient did not discharge any discomfort post-operation. For patients with atrial myxoma, early diagnosis is essential, anticoagulant or antithrombotic therapy and surgery have a great importance to prevent further embolism.